Chondroitin Sulfate Proteoglycan 4 and Its Potential as an Antibody Immunotherapy Target Across Different Tumor Types
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01911
Full Text
Open PDFAbstract
Available in full text
Date
January 10, 2018
Authors
Publisher
Frontiers Media SA